<DOC>
	<DOCNO>NCT00370968</DOCNO>
	<brief_summary>Three-hundred-and-fifty-two male age 1-36 month acute non-dysenteric diarrhoea systemic illness enrol clinical trial . Eligible child stratify age ( 1up 5 month , 6-35 month ) . Within two age stratum patient randomize receive zinc-ORS ( fortified 40 mg elemental zinc zinc gluconate per litre ) standard WHO ORS . The major outcome measure stool output duration diarrhea . The safety administer zinc determine examine effect zinc ingestion vomiting , sodium potassium homeostasis , plasma zinc copper , iron store concentration serum transferrin receptor .</brief_summary>
	<brief_title>Zinc-ORS Severe Complicated Acute Diarrhea</brief_title>
	<detailed_description>Zinc deficiency prevalent develop country due inadequate food intake , low intake food animal source high dietary intake phytate , substance reduces zinc absorption . A recently complete trial All India Institute Of Medical Sciences ( AIIMS ) measure effect zinc-ORS community , episodes relatively mild . Zinc-ORS efficacious reduce total number stool ( 19 % relative risk reduction , 95 % CI 15 % 23 % ) duration diarrhoea ( 11 % relative risk reduction , 95 % CI 4 % 24 % ) . In order make policy decision standard ORS provide child fortify zinc national ( international ) child health program need similar evidence base also child hospitalize acute diarrhea . This child represent severe end disease spectrum , i.e . one high risk die . The primary objective conduct study zinc-ORS hospital setting ( i.e . severe diarrhea ) optimize accurately measure amount zinc-ORS consume monitor stool output possible field setting . The study also examine safety use zinc-ORS ; whether zinc-ORS affect blood level sodium potassium micronutrient zinc , copper iron . The study contribute introduce efficacious ORS help increase ORS use rate continue important public health challenge India . The study carry two Clinical Research Facilities supervise Centre Diarrhoeal Diseases Nutrition Research , Division Gastroenterology , Department Pediatrics , AIIMS . 352 male age 1-36 month acute non-dysenteric diarrhoea systemic illness enrol . Eligible child first stratify age ( 1up 5 month , 6-35 month ) . Within two age stratum patient randomize receive zinc-ORS ( fortified 40 mg elemental zinc zinc gluconate per litre ) standard WHO ORS . The major outcome measure stool output duration diarrhea . The safety administer zinc determine examine effect zinc ingestion vomiting , sodium potassium homeostasis , plasma zinc copper , iron store concentration serum transferrin receptor . Minimum period study 48 hour subject discharge diarrhoea cease 48 hour , whichever later .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dehydration</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>Males Age 1 month 36 month : Passage 3 liquid stool 24hour period , every day , least one 12 hour prior admission Diarrhea &lt; 7days ( 168 hour ) severe systemic illness require intensive care management ; systemic infection suspect general appearance nonwellbeing one follow symptom : shrill cry irritability , temperature instability , hypotension , hypoglycemia , alter sensorium , lethargy refusal feed , abdominal distension . chronic illness like Tuberculosis , Nephrotic syndrome , malignancy etc surgical disorder . severe malnutrition ( weight age &lt; 65 % NCHS median gross blood stool refusal consent</criteria>
	<gender>Male</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Children</keyword>
	<keyword>India</keyword>
	<keyword>Hospital</keyword>
	<keyword>Zinc</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Treatment</keyword>
</DOC>